- Home
- CLOV vs ELVN Comparison
CLOV vs ELVN Comparison
Compare CLOV & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLOV
- ELVN
- Stock Information
- Founded
- CLOV 2014
- ELVN 2016
- Country
- CLOV United States
- ELVN United States
- Employees
- CLOV N/A
- ELVN N/A
- Industry
- CLOV Medical Specialities
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- CLOV Health Care
- ELVN Health Care
- Exchange
- CLOV Nasdaq
- ELVN Nasdaq
- Market Cap
- CLOV 1.4B
- ELVN 1.2B
- IPO Year
- CLOV N/A
- ELVN 2020
- Fundamental
- Price
- CLOV $3.12
- ELVN $18.43
- Analyst Decision
- CLOV Strong Buy
- ELVN Strong Buy
- Analyst Count
- CLOV 3
- ELVN 5
- Target Price
- CLOV $4.37
- ELVN $41.20
- AVG Volume (30 Days)
- CLOV 4.8M
- ELVN 487.3K
- Earning Date
- CLOV 11-05-2025
- ELVN 11-12-2025
- Dividend Yield
- CLOV N/A
- ELVN N/A
- EPS Growth
- CLOV N/A
- ELVN N/A
- EPS
- CLOV N/A
- ELVN N/A
- Revenue
- CLOV $1,607,900,000.00
- ELVN N/A
- Revenue This Year
- CLOV $39.93
- ELVN N/A
- Revenue Next Year
- CLOV $28.94
- ELVN $25.00
- P/E Ratio
- CLOV N/A
- ELVN N/A
- Revenue Growth
- CLOV 22.12
- ELVN N/A
- 52 Week Low
- CLOV $2.12
- ELVN $13.30
- 52 Week High
- CLOV $4.87
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- CLOV 64.84
- ELVN 38.66
- Support Level
- CLOV $3.00
- ELVN $18.80
- Resistance Level
- CLOV $3.24
- ELVN $20.30
- Average True Range (ATR)
- CLOV 0.11
- ELVN 1.09
- MACD
- CLOV 0.06
- ELVN -0.18
- Stochastic Oscillator
- CLOV 82.09
- ELVN 12.77
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.